Differential serum cytokine levels are associated with cytokine gene polymorphisms in north Indians with active pulmonary tuberculosis

Infection, Genetics and Evolution

Volumn 11, Issue 5, 2011, Pages 1015-1022

  Abhimanyu, ^a   Mangangcha, Irengbam Rocky ^a   Jha, Pankaj ^a   Arora, Komal ^b   Mukerji, Mitali ^c   Banavaliker, Jayant Nagesh ^b   Brahmachari, Vani ^d   Bose, Mridula ^a  

^a UNIVERSITY OF DELHI   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^c Rajan Babu Institute of Pulmonary Medicine and TB   (India)

^d UNIVERSITY OF DELHI   (India)

Author keywords

Cytokine gene polymorphisms; Population stratification; Pulmonary tuberculosis; Serum cytokine

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA INTERFERON GENE; GENE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INDIAN; INTERLEUKIN 10 GENE; INTERLEUKIN 12 GENE; INTERLEUKIN 4 GENE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE;

CYTOKINES; DNA; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79956298540     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.03.017     Document Type: Article

References (49)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
2. Akahoshi M., Nakashima H., Miyake K., Inoue Y., Shimizu S., et al. Influence of Interleukin-12 receptor β1 polymorphism on tuberculosis. Hum. Genet. 2002, 112:237-243.
3. Ansari A., Talat N., Jamil B., Hasan Z., Razzaki T., et al. Cytokine gene polymorphism across tuberculosis clinical spectrum in Pakistani patients. PLOS one 2009, 4:e4478.
4. Barnes P.F., Abrams J.S., Lu S., Sieling P.A., Rea T.H., et al. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect. Immun. 1993, 61:197-203.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
6. Basham T.Y., Merigan T.C. Recombinant interferon-g increases HLA-DR synthesis and expression. J. Immunol. 1983, 130:1492-1494.
7. Boraska V., Zeggini E., Groves C.J., Rayner N.W., Âkrabić V., et al. Family-based analysis of tumor necrosis factor and lymphotoxin-α tag polymorphisms with type 1 diabetes in the population of South Croatia. Hum. Immunol. 2009, 70:195-199.
8. Bossé Y., Lemire M., Poon A.H., Daley D., He J.Q., Sandford A., White J.H., James A.L., Musk A.W., Palmer L.J., Raby B.A., Weiss S.T., Kozyrskyj A.L., Becker A., Hudson T.J., Laprise C. Asthma and genes encoding components of the vitamin D pathway. Respir. Res. 2009, 10:98.
9. Chakraborty A.K. Epidemiology of tuberculosis: current status in India. Indian J. Med. Res. 2004, 120:248-276.
10. Choudhry S., Coyle N.E., Tang H., Salari K., Lind D., Clark S.L. Population stratification confounds genetic association studies among Latinos. Hum. Genet. 2006, 118:652-664.
11. Cooke G.S., Campbell S.J., Sillah J., Gustafson P., Bah B., Sirugo G., Bennett S., McAdam K.P.W.J., Sow O., Lienhardt C., Hill A.V.S. Polymorphism within the interferon-γ receptor complex is associated with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2006, 174:339-343.
12. Danis V.A., Millington M., Hyland V.J., Grennan D Cytokine production by normal human monocytes: intersubject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 1995, 99:303-310.
13. Deveci F., Akbulut H.H., Turgut T., Muz H.M. Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm. 2005, 5:256-262.
14. Devlin B., Roeder K. Genomic control for association studies. Biometrics 1999, 55:997-1004.
15. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001, 19:93-129.
16. Fulton S.A., Cross J.V., Toossi Z.T., Boom W.H. Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J. Infect. Dis. 1998, 178:1105-1114.
17. Gong J., Zhang M., Modlin R.L., Linsley P.S., Iyer D., Lin Y., Barnes P.F. Interleukin-10 downregulates Mycobacterium tuberculosis induced Th1 responses and CTLA-4 expression. Infect. Immun. 1996, 64:913-918.
18. Heiman G.A., Hodge S.E., Prakash G., Zhang J., Greenberg D.A. Effect of population stratification on case-control association studies. Hum. Hered. 2004, 58:30-39.
19. Henderson R.A., Watkins S.C., Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 1997, 159:635-643.
20. Hirsch C.S., Toossi Z., Othieno C., Johnson J.L., Schwander S.K., Robertson S., Wallis R.S., Edmonds K., Okwera A., Mugerwa R., Peters P., Ellner J.J. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 1999, 180:2069-2073.
21. Hurme M., Santilla S. IL-1receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur. J. Immunol. 1998, 28:2598-2602.
22. Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet. 2008, 87:3-20. Indian Genome Variation Consortium.
23. Keane J., Balcewicz-Sablinska M.K., Remold H.G., Chupp G.L., Meek B.B., Fenton M.J., Kornfeld H. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 1997, 65:298-304.
24. Ladel C.H., Blum C., Dreher A., Reifenberg K., Kaufmann S.H. Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur. J. Immunol. 1995, 25:2877-2881.
25. Lopez-Maderuelo D., Arnalich F., Serantes R., Gonzalez A., Codoceo R., Madero R., Vázquez J.J., Montiel C. Interferon-γ and interleukin-10 gene polymorphism in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2003, 167:970-975.
26. Lucey D.R., Clerici M., Shearer G.M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 1996, 9:532-562.
27. Möller M., Nebel A., Helden P.D.V., Schreiber S., Hoal E.G. Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study. BMC Infect. Dis. 2010, 10:154.
28. Morahan G., Kaur G., Singh M., Rapthap C.C., Kumar N., Katoch K., Mehra N.K., Huang D. Association of variants in the IL12B gene with leprosy and tuberculosis. Tissue Antigens 2007, 69:234-236.
29. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and anti-microbial activity. J. Exp. Med. 1983, 58:670-689.
30. Orme I.M., Cooper A.M. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today 1999, 20:307-312.
31. Pace J.L., Russell S.W., Torres B.A., Johnson H.M., Gray P.W. Recombinant mouse γ-interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 1983, 130:2011-2013.
32. Pieters J., Garfield J. Hijacking the host: survival of pathogenic mycobacterial inside macrophages. Trends Microbiol. 2002, 10:142-146.
33. Powrie F., Coffman R.L. Inhibition of cell-mediated immunity by IL-4 and IL-10. Res. Immunol. 1993, 144:639-643.
34. Price A.L., Patterson J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
35. Schultz R.M., Kleinschmidt W. Functional identity between murine interferon and macrophage activating factor. Nature 1983, 305:239-240.
36. Selvaraj P., Alagarasu K., Harishankar M., Vidyarani M., Nisha R.D., Narayanan P.R. Cytokine gene polymorphisms and cytokine levels in pulmonary tuberculosis. Cytokine 2008, 43:26-33.
37. Sharma S., Rathored J., Ghosh B., Sharma S.K. Genetic polymorphisms in TNF genes and tuberculosis in North Indians. BMC Infect. Dis. 2010, 10:165.
38. Shaw T.C., Thomas L.H., Friedland J.S. Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells. Cytokine 2000, 12:483-486.
39. Shin H.D., Park B.L., Kim L.H., Cheong H.S., Lee I.H., Park S.K. Common interleukin 10 polymorphism associated with decreased risk of tuberculosis. Exp. Mol. Med. 2005, 37:128-132.
40. Torrico F., Heremans H., Rivera M.T., Marck V.E., Billiau A., Carlier Y. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 1991, 146:3626-3632.
41. Tsilidis K.K., Helzlsouer K.J., Smith M.W., Grinberg V., Hoffman-Bolton J., Clipp S.L., Visvanathan K., Platz E.A. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 2009, 20:1739-1751.
42. Tso H.W., Lau Y.L., Tam C.M., Wong H.S., Chiang A.K.S. Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese Population. J. Infect. Dis. 2004, 190:913-919.
43. Vallinoto A.C.R., Graça E.S., Araújo M.S., Azevedo V.N., Cayres-Vallinoto I., Machado L.F., Ishak M.O., Ishak R. IFN-γ +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. Hum. Immunol. 2010, 71:692-696.
44. Verbon A., Juffermans N., Van Deventer S.J.H., Speelman P., Van Deutekom H. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 1999, 115:110-113.
45. Vidyarani M., Selvaraj P., Prabhu Anand S., Jawahar M.S., Adhilakshmi A.R., Narayanan P.R. Interferon gamma (IFN-γ) and interleukin-4 (IL-4) gene variants and cytokine levels in pulmonary tuberculosis. Indian J. Med. Res. 2006, 124:403-410.
46. Wilkinson R.J., Patel P., Llewelyn M., Hirsch C.S., Pasvol G., Snounou G., Davidson R.N., Toossi Z. Influence of polymorphism in the genes for the Interleukin (IL)-1 receptor and IL-1β on tuberculosis. J. Exp. Med. 1999, 189:1863-1873.
47. Wurfel M.M., Gordon A.C., Holden T.D., Radella F., Strout J., Kajikawa O., Ruzinski J.T., Rona G., Black R.A., Stratton S., Jarvik G.P., Hajjar A.M., Nickerson D.A., Rieder M., Sevransky J., Maloney J.P., Moss M., Martin G., Shanholtz C., Garcia J.G., Gao L., Brower R., Barnes K.C., Walley K.R., Russell J.A., Martin T.R. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am. J. Respir. Crit. Care Med. 2008, 178:710-720.
48. Yilmaz V., Yentur S.P., Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005, 30:188-194.
49. Young D., Hussel T., Dougan G. Chronic bacterial infections: living with unwanted guests. Nat. Immunol. 2002, 3:1026-1032.